Vol 13, No 6 (June 30, 2024): Translational Lung Cancer Research

Editorial

Adaptive medicine, a crucial component of optimized decision making: perspectives from lung cancer management
Wenhua Liang, Ran Zhong, Jianxing He
Translational Lung Cancer Research  
2024;
13
(6)
:1185-1189
.
 (30 June 2024) 
PDF Full Text (796) Peer Review File COI Form Open Access Get Permission

Original Article

The impact of different modalities of chemoradiation therapy and chemotherapy regimens on lymphopenia in patients with locally advanced non-small cell lung cancer
Yaqi Li, Xingwen Fan, Yulei Pei, Qi Yu, Renquan Lu, Guoliang Jiang, Kailiang Wu
Translational Lung Cancer Research  
2024;
13
(6)
:1190-1200
.
 (30 June 2024) 
PDF Full Text (1473) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
Segmentectomy versus lobectomy for ground-glass opacity dominant cT1N0 invasive lung adenocarcinoma
Zelin Ma, Yang Zhang, Han Han, Shengping Wang, Yuan Li, Haiquan Chen
Translational Lung Cancer Research  
2024;
13
(6)
:1201-1209
.
 (30 June 2024) 
PDF Full Text (1717) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
Association between strenuous sports or other exercises and lung cancer risk: a mendelian randomization study
Wushu Chen, Anlin Liu, Yu Jiang, Yuechun Lin, Xingpei Li, Chongde Pan, Yixuan Wang, Huiwen Yu, Yulin Zhao, Junxing Li, Hengrui Liang, Runchen Wang, Wei Wang, Xin Xu, Ying Huang
Translational Lung Cancer Research  
2024;
13
(6)
:1210-1221
.
 (30 June 2024) 
PDF Full Text (3304) Reporting Checklist Peer Review File COI Form Open Access Get Permission
Clinical impact of EGFR and KRAS mutations in surgically treated unifocal and multifocal lung adenocarcinoma
Jiahao Jiang, Mark F. Berry, Natalie S. Lui, Douglas Z. Liou, Winston L. Trope, Leah M. Backhus, Joseph B. Shrager
Translational Lung Cancer Research  
2024;
13
(6)
:1222-1231
.
 (30 June 2024) 
PDF Full Text (1274) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
Predicting MET exon 14 skipping mutation in pulmonary sarcomatoid carcinoma by whole-tumour texture analysis combined with clinical and conventional contrast-enhanced computed tomography features
Lei Miao, Tian Qiu, Yan Li, Jianwei Li, Xu Jiang, Mengwen Liu, Xue Zhang, Jiuming Jiang, Huanhuan Zhang, Yanmei Wang, Xiao Li, Jianming Ying, Meng Li
Translational Lung Cancer Research  
2024;
13
(6)
:1232-1246
.
 (30 June 2024) 
PDF Full Text (1158) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
Predictive value of delta-radiomic features for prognosis of advanced non-small cell lung cancer patients undergoing immune checkpoint inhibitor therapy
Xiaoyu Han, Yujin Wang, Xi Jia, Yuting Zheng, Chengyu Ding, Xiaohui Zhang, Kailu Zhang, Yunkun Cao, Yumin Li, Liming Xia, Chuansheng Zheng, Jing Huang, Heshui Shi
Translational Lung Cancer Research  
2024;
13
(6)
:1247-1263
.
 (30 June 2024) 
PDF Full Text (1449) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
Heterogeneity of lymphocyte subsets in predicting immune checkpoint inhibitor treatment response in advanced lung cancer: an analysis across different pathological types, therapeutic drugs, and age groups
Chuanwang Miao, Yuanji Chen, Hao Zhang, Wei Zhao, Cunliang Wang, Zeliang Ma, Shan Zhu, Xudong Hu
Translational Lung Cancer Research  
2024;
13
(6)
:1264-1276
.
 (30 June 2024) 
PDF Full Text (1249) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
Bioinformatics analysis of an immunotherapy responsiveness-related gene signature in predicting lung adenocarcinoma prognosis
Yupeng Jiang, Bacha Hammad, Hong Huang, Chenzi Zhang, Bing Xiao, Linxia Liu, Qimi Liu, Hengxing Liang, Zhenyu Zhao, Yawen Gao
Translational Lung Cancer Research  
2024;
13
(6)
:1277-1295
.
 (30 June 2024) 
PDF Full Text (1712) Reporting Checklist Peer Review File COI Form Open Access Get Permission
Correlation analysis between driver gene mutation and clinicopathological features in lung adenocarcinoma based on real-world cumulative clinical data
Sheng Lu, Aotian Guo, Haichuan Hu, Xinxin Ying, Yao Li, Zhengwei Huang, Wangjue Xu, Shen Tao, Xiaotong Hu, Na Yan, Xuan Zhang, Dan Shen, Takaaki Sasaki, Surein Arulananda, Ken Onodera, Zhengfu He
Translational Lung Cancer Research  
2024;
13
(6)
:1296-1306
.
 (30 June 2024) 
PDF Full Text (1635) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
The prognostic role of albumin levels in lung cancer patients receiving third-line or advanced immunotherapy: a retrospective study
Yanfei Chen, Tong Liu, Hui Feng, Tiantian Liu, Jing Zhang, Jun Wang, Jihong Lu, Antonio Rossi, Ivy Riano, Pingping Hu, Jiandong Zhang
Translational Lung Cancer Research  
2024;
13
(6)
:1307-1317
.
 (30 June 2024) 
PDF Full Text (1261) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
Predicting complication risks after sleeve lobectomy for non-small cell lung cancer
Yiming He, Lin Huang, Jiajun Deng, Yifan Zhong, Tao Chen, Yunlang She, Lei Jiang, Deping Zhao, Dong Xie, Gening Jiang, Stefano Bongiolatti, Mara B. Antonoff, René Horsleben Petersen, Chang Chen
Translational Lung Cancer Research  
2024;
13
(6)
:1318-1330
.
 (30 June 2024) 
PDF Full Text (1105) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
PSME3 promotes lung adenocarcinoma development by regulating the TGF-β/SMAD signaling pathway
Shuai Wang, Yongmeng Li, Kai Jin, Kenichi Suda, Rongyang Li, Huiying Zhang, Hui Tian
Translational Lung Cancer Research  
2024;
13
(6)
:1331-1345
.
 (30 June 2024) 
PDF Full Text (1256) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
Peptidyl-prolyl isomerase F as a prognostic biomarker associated with immune infiltrates and mitophagy in lung adenocarcinoma
Zitong Feng, Lin Yuan, Luyuan Ma, Wenhao Yu, Fayez Kheir, Lukas Käsmann, Wolfgang M. Brueckl, Kai Jin, Dingxin Wang, Yi Shen, Rongyang Li, Hui Tian
Translational Lung Cancer Research  
2024;
13
(6)
:1346-1364
.
 (30 June 2024) 
PDF Full Text (1520) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
Tumor mutation burden and FAT3 mutation influence long-term survival in surgically resected small cell lung cancer
Xinyu Qian, Lin Zhu, Na Han, Jing Qin
Translational Lung Cancer Research  
2024;
13
(6)
:1365-1375
.
 (30 June 2024) 
PDF Full Text (1047) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
Pathological and imaging features of pulmonary invasive mucinous adenocarcinoma—a retrospective cohort study
Xinfu Pan, Renxiu Fang, Binjie Zhang, Zhijun Chen, Shanhua Zhang, Hanbo Le, Helmut H. Popper, Lu Liu, Yongkui Zhang
Translational Lung Cancer Research  
2024;
13
(6)
:1376-1382
.
 (30 June 2024) 
PDF Full Text (1630) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission

Review Article

Narrative review of stereotactic body radiation therapy combined with tyrosine kinase inhibitors for oligometastatic EGFR-mutated non-small cell lung cancer: present and future developments
Xinchen Zhao, Shengwei Zhang, Xiaoyue Sun, Yao Lin, Luca Capone, Eric C. Ko, Benjamin H. Kann, Yi Li, Xiaoshan Wang
Translational Lung Cancer Research  
2024;
13
(6)
:1383-1395
.
 (30 June 2024) 
PDF Full Text (1740) Reporting Checklist Peer Review File COI Form Open Access Get Permission

Case Report: iMDT Corner

Radical resection in a patient with stage IIIA non-small cell lung cancer with the EGFR exon 19 deletion mutation after neoadjuvant targeted therapy with osimertinib: a case report
Hao Chen, Jiarong Zhang, Atsushi Osoegawa, Lorenzo Calvetti, Palma Fedele, Chun Chen, Bin Zheng
Translational Lung Cancer Research  
2024;
13
(6)
:1396-1406
.
 (30 June 2024) 
PDF Full Text (1570) Reporting Checklist Peer Review File COI Form Open Access Get Permission

Case Report

Prominent response to savolitinib monotherapy in high-grade fetal adenocarcinoma with MET amplification and concurrent brain metastasis: a case report
Lan Shen, Jikai Zhao, Ying Yang, Shuya Mu, Yongfeng Yu, Yuchen Han, Shun Lu
Translational Lung Cancer Research  
2024;
13
(6)
:1407-1413
.
 (30 June 2024) 
PDF Full Text (1013) Reporting Checklist Peer Review File COI Form Open Access Get Permission
Neoadjuvant aumolertinib monotherapy for EGFR-mutant lung squamous cell carcinoma: a case report
Yue Liu, Xiaoxia Yan, Dongliang Bian, Kaixing Ai, Yuming Zhu
Translational Lung Cancer Research  
2024;
13
(6)
:1414-1419
.
 (30 June 2024) 
PDF Full Text (1148) Reporting Checklist Peer Review File COI Form Open Access Get Permission
Major pathological response obtained after neoadjuvant chemotherapy combined with dual immunotherapy for malignant pleural mesothelioma: a case report
Yuchen Zhang, Guangyin Zhao, Chen Xu, Jie Gu, Di Ge
Translational Lung Cancer Research  
2024;
13
(6)
:1420-1425
.
 (30 June 2024) 
PDF Full Text (1167) Reporting Checklist Peer Review File COI Form Open Access Get Permission

Editorial Commentary

The combination of osimertinib and savolitinib as molecular inhibition of EGFR and MET receptors may be selected to provide maximum effectiveness and acceptable toxicity
Dariusz M. Kowalski, Magdalena Zaborowska-Szmit, Sebastian Szmit, Piotr Jaśkiewicz, Maciej Krzakowski
Translational Lung Cancer Research  
2024;
13
(6)
:1426-1431
.
 (30 June 2024) 
PDF Full Text (1568) Peer Review File COI Form Open Access Get Permission
The APPLE trial in the evolving landscape of ctDNA monitoring
Danielle Brazel, Misako Nagasaka
Translational Lung Cancer Research  
2024;
13
(6)
:1432-1437
.
 (30 June 2024) 
PDF Full Text (903) Peer Review File COI Form Open Access Get Permission
Diagnosis and treatment of non-small cell lung cancer (NSCLC) harboring MET Ex14 skipping: have we met the desired drug?
Go Makimoto
Translational Lung Cancer Research  
2024;
13
(6)
:1438-1443
.
 (30 June 2024) 
PDF Full Text (1152) Peer Review File COI Form Open Access Get Permission
Pros and cons of subcutaneous (SC) versus intravenous (IV) administration of immune checkpoint inhibitors in non-small cell lung cancer
Julie Moeller, Michael D. Green, Nithya Ramnath
Translational Lung Cancer Research  
2024;
13
(6)
:1444-1449
.
 (30 June 2024) 
PDF Full Text (7238) Peer Review File COI Form Open Access Get Permission